Skip to main content
Tech.euFundingExplorerBeta

Kiin Bio

The next breakthrough in drug discovery is a team of Virtual Scientists that designs, runs and interprets complex experiments by intelligently using the right software and data. Kiin AI is bringing this vision to life with KiinOS

Kiin Bio has raised €1.9M across 1 funding round from 4 investors, most recently a Pre-Seed round in Jun 2025. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.9M
€1,900,463
Funding rounds
1
Investors
4
distinct backers
Active since
2025-06
latest 2025-06

Funding by year

EUR raised per year
Kiin Bio — funding by year — interactive chart.
Data table
Kiin Bio — funding by year
2025€1.9M

Signals

High confidence
Raise-next likelihood32
base rate 24% for Pre-Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-06-05Pre-Seed€1.9Mb2venture,Business Angels,Heartfelt,rule30View deal →

Investors

4

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData